glp 1 colon cancer Widely used metabolic drugs may help curb rising colorectal in younger adults Glucagon-like peptide 1 receptor agonists

Originally characterized at the University of Florida by the Stephen ORahilly and Robert Kraft groups, the compound has been studied in preclinical research for body composition, adipose tissue lipolysis, glucose homeostasis, skeletal muscle aging, and metabolic disease endpoints

Abegg D, Tomanik M, Qiu N, Pechalrieu D, Shuster A, Commare B, et al

Overall, more time is needed to determine whether or not GLP-1 drugs can be used to control autoimmunity and inflammation in those with or without obesity and how best to utilize the medications for these purposes

Stay Ahead in Immunology Updates

Patients appreciate having a centralized location for their treatment history, appointment scheduling, and the Medvi refill intake form